FOLFOXIRI Plus Bevacizumab With or Without Atezolizumab as 1st Line Treatment of pMMR and IS IC-High Metastatic Colorectal Cancer Patients.
Clinical trial NCT06733038 · RECRUITING
Trial details
- NCT number
- NCT06733038
- Sponsor
- Gruppo Oncologico del Nord-Ovest
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-15
- Primary completion
- 2028-04-01
- Enrollment
- 238
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.